Recent advances and clinical relevance of microbiome dynamics in health and disease
Narrative review synthesizes evidence on the human microbiome's role across multiple organ systems and current therapeutic strategies.
| Population | — |
|---|---|
| Intervention | — |
| Comparator | — |
| Outcome | — |
What the study showed
The abstract describes commensal microbes' beneficial roles in immune tolerance and metabolic balance. It analyzes the effects of diet, geography, and medication exposure on microbial composition, and the consequences of dysbiosis across gastrointestinal, metabolic, neurological, cardiovascular, autoimmune, and oncological conditions. It also examines how the microbiome modulates drug absorption, metabolism, and efficacy.
How it was done
This is a narrative review synthesizing findings from multiple biomedical fields. No systematic search strategy, inclusion criteria, or formal quality assessment of primary studies is described in the abstract.
Risk of bias
Narrative design without declared systematic methodology is prone to selection bias. The abstract is truncated, precluding assessment of final conclusions and the true scope of the synthesis.
What this study does NOT prove
The review does not demonstrate efficacy of any specific microbiome intervention nor establishes causality between dysbiosis and any particular disease.
In clinical practice
The review may support conceptual updates for clinicians but does not provide sufficient grounds for isolated changes in clinical practice. Therapeutic recommendations from narrative reviews require confirmation by controlled trials.
Limitations
Narrative design without declared systematic methodology is prone to selection bias. The abstract is truncated, precluding assessment of final conclusions and the true scope of the synthesis.
Technical appendix
Version history
- 1.0 · 2026-09-06 — Auto-generated under Evidence Standard v1.0
Paid access: structured summary from public metadata; consult the original study at the source.